Evaluation of oxidative stress markers in hematologic diseases

Evaluation of oxidative stress markers in hematologic diseases - Evaluation of oxidative stress markers in hematologic diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014411

Enrollment

200

Registered

2014-06-29

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: newly diagnosed patients with hematologic diseases. healthy volunteers as normal control.

Exclusion criteria

Exclusion criteria: 1)Patients with double cancer. 2)Patients with severe active infection. 3)Patients with urinary tract infection. 4)Patients with gross hematuria. 5)Patients with severe mental disorder. 6)Patients who are considered unsuitable for the study by attending physician.

Design outcomes

Primary

Measure	Time frame
comparison of oxidative stress marker levels between healthy control and patients with hematologic diseases.	—

Secondary

Measure	Time frame
1)relationship between oxidative stress markers and various prognostic factors. 2)relationship between oxidative stress markers and response rare(RR). 3)relationship between oxidative stress markers and overall survival.	—

Countries

Japan

Contacts

Public ContactTomonori Nakazato

Yokohama Municipal Citizen's Hospital Department of Hematology

n-tomo@eurus.dti.ne.jp045-331-1961

Outcome results